Eli Lilly and Company (LLY) Announces New Phase 3 Trial Results for Orforglipron
Yahoo Financearrow_outwardEli Lilly’s Promising Diabetes Study: Retatrutide in Focus
TipRanksarrow_outwardWhy Eli Lilly Stock Was Looking Sickly Today - sharewise.com
Sharewise.comarrow_outward(LLY) Investment Report - news.stocktradersdaily.com
News.stocktradersdaily.comarrow_outwardNew Clinical Data: Lilly's Alzheimer's Drug Kisunla Demonstrates Increasing Benefits Over 3 Years - Stock Titan
Stock Titanarrow_outwardEli Lilly (LLY) Stock Dips on Novo Nordisk Guidance Update - GuruFocus
GuruFocusarrow_outwardWhy Eli Lilly Stock Was Looking Sickly Today - The Globe and Mail
The Globe and Mailarrow_outwardWhy Eli Lilly Stock Was Looking Sickly Today - The Motley Fool
The Motley Foolarrow_outwardMorgan Stanley Remains Bullish on Eli Lilly (LLY) - MSN
MSNarrow_outwardWhy Eli Lilly (LLY) Stock Is Falling Today - FinancialContent
FinancialContentarrow_outwardNovo Nordisk Implodes After Wegovy Warning—Is The Weight-Loss Bubble Bursting? - Benzinga
Benzingaarrow_outwardEli Lilly (LLY) Stock Set to Gain on Early Alzheimer’s Trial Results, Says BMO Capital - Insider Monkey
Insider Monkeyarrow_outwardEli Lilly (LLY) Gains CHMP Approval for Donanemab in Alzheimer's Treatment - simplywall.st
Simplywall.starrow_outwardIs Eli Lilly Stock A Buy On A Fresh Bout Of Alzheimer's News? - Investor's Business Daily
Investor's Business Dailyarrow_outwardWhy Eli Lilly (LLY) is a Top Growth Stock for the Long-Term - Nasdaq
Nasdaqarrow_outwardLLY Stock Maintains Buy Rating Amid GLP-1RA and Alzheimer's Market Advantages - AInvest
AInvestarrow_outwardLobbying Update: $2,700,000 of ELI LILLY AND COMPANY lobbying was just disclosed | LLY Stock News - Quiver Quantitative
Quiver Quantitativearrow_outwardEli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (July 2025) - 24/7 Wall St.
24/7 Wall St.arrow_outwardDon’t Miss Out: 3 Blue-Chips Set to Pop This Earnings Season - MarketBeat
MarketBeatarrow_outwardEli Lilly (LLY) Faces Bearish Options Flow, But Probabilities Tell A Different Story - Barchart.com
Barchart.comarrow_outwardEli Lilly: The Buy Case Gets Stronger (Rating Upgrade) (NYSE:LLY) - Seeking Alpha
Seeking Alphaarrow_outwardLLY Stock Too Cheap At $750? - Forbes
Forbesarrow_outwardLLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study - Zacks Investment Research
Zacks Investment Researcharrow_outward
Lly Stock close
- 2025-07-31 18:50 event
- 23 sourceslanguage
- 200+ ads_click
- 1 day ago schedule